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The eﬃcacy of acupuncture in smoking cessation, and its eﬀect on the urge to smoke are unclear. We evaluated the eﬀect of a
standardized protocol of transcutaneous electric acupoint stimulations (TEAS) on alleviating the urge to smoke. Ninety-eight
smokers were recruited in two double-blind studies. Participants abstained from smoking for 26h, and were randomized to
receive TEAS alternating between 2 and 100Hz at four acupoints (LI4 and PC8, PC6 and TE5) at four diﬀerent intensities (10, 5,
Intermittent 5 or 0mA). The urge to smoke was assessed by the Questionnaire of Smoking Urges (QSU-Brief). In Experiment 1,
the 10mA group (n = 20) was compared with the 5mA group (n = 20); the increase in smoking urges did not diﬀer signiﬁcantly.
Consideringthepossibilitythat5mAmaybeanactiveintervention,inExperiment 2,atrueplacebo (0mA),andaproxyofplacebo
[Intermittent 5mA (i5mA)] were compared with 10 mA TEAS. In this experiment, 10mA (n = 20) TEAS showed a tendency to
alleviate smoking urges compared with 0mA (n = 16), and i5 mA (n = 19) TEAS. Only when the data of smokers with Fagerst¨ om
Test for Nicotine Dependence score ≥5 were analyzed that the diﬀerence between the 10mA group and the control group (0 and
i5mA) became signiﬁcant. Based on these preliminary ﬁndings, we conclude that TEAS applied on the skin may antagonize the
increase in urge to smokein abstinent-dependent smokers.It seems warranted to assess the eﬃcacy of TEAS in smokingcessation
clinical trials involving a larger population of dependent smokers.
1.Introduction
Several types of interventions, such as counseling [1], nico-
tine replacement therapies (NRT) [2], or psychotropic drugs
such as bupropion [3]h a v es h o w ne ﬃcacy in smoking ces-
sation. Less-studied complementary interventions, includ-
ing relaxation, acupuncture, electro-acupuncture, hypnosis,
meditation, green tea, Vitamin C or E, are increasingly
sought-after alternative therapies by smokers who wish to
quit smoking [4]. However, their eﬃcacy is yet to be con-
ﬁrmed. Uncontrolled studies have suggested that acupunc-
ture might reduce the symptoms of nicotine withdrawal, and
some high rates of initial success have been reported [5].
Many literature reviews of controlled trials of acupuncture
for smoking cessation have been published [6–13], but their
conclusions have been found to be inconsistent. A recent
Cochrane review [14] concluded that despite the relatively
high number [15] of studies, there was no consistent evi-
dence that acupuncture was eﬀective for smoking cessation.
Firm conclusions could not be drawn because of meth-
odological inadequacies in the studies, such as the failure to
validate smoking cessation, inadequate details of random-
ization procedures and failure to minimize the investigators’
inﬂuence on the subjects. It was thus concluded that further
well-designed studies were justiﬁed.2 Evidence-Based Complementary and Alternative Medicine
Acupuncture can be applied in diﬀerent ways. Manual
needling is the classic method, and electro-acupuncture
(EA), that is, electrical stimulation is introduced to the body
via metallic needles inserted into the acupoints is the most
commonly used modality today [16], which has a character-
istic feature of highly reproducible stimulation parameters,
and great savings in manpower. However, in the case of the
treatment of drug dependence, there is often an urgent need
for treatment when a craving episode suddenly occurs. It is
almost impossible for the subject to ﬁnd an acupuncturist
within a few minutes before he/she is compulsively rushing
for the drug. An alternative is to use skin electrodes to apply
electrical stimulation on the acupoints by the patient him-
self/herself, with a method called transcutaneous electrical
acupoint stimulation (TEAS).
A thorough study has been made to compare the eﬀec-
tiveness of EA and TEAS in producing antinociceptive eﬀect
in rats [17]. The results showed that TEAS was as eﬀective
as EA, if not more, in terms of its antinociceptive eﬃcacy,
and that both eﬀectscould be blockedby the opioid receptor
antagonist naloxone to the same extent. In a recent study
performed in humans on former heroin addicts, the video
cue-induced craving assessed by the visual analog scale
(VAS),aswellastheaccompanyingchangesoftheautonomic
function (increase of blood pressure and heart rate) was
eﬀectivelycontrolled by the TEAS using the HANSunit [18].
While the eﬀect of acupuncture has been the subject of
increasing amount of research, the central activation pattern
inducedbyacupuncture(increasedproductionandreleaseof
morphine-like substances such as enkephalins, endorphins,
dynorphins and other neurotransmitters) has only recently
been clariﬁed in animal model [16, 19], and in humans [20].
The parameters (intensity, frequency and locations of the
acupoints) of EA for opioid addiction have been evaluated
in considerable detail [18, 19, 21–24]. According to these
ﬁndings, a speciﬁc standardized protocol of TEAS was es-
tablished, and animal studies demonstrated that the eﬀect of
TEAS was very similar, if not more potent, than EA [17].
Acutecravingsforcigarettes(i.e.,theurgetosmoke)have
repeatedly been associated with relapses, and are identiﬁed
as having a critical role in promoting smoking relapse [15].
Therefore, relieving the urge to smoke may be a major goal
for demonstrating the potential clinical eﬀect of a treatment
on abstinence. It can thus be hypothesized that if TEAS
decreases the urge to smoke, it can later be considered as a
potential therapeutic tool, and can be assessed in a random-
ized controlled therapeutic trial of smoking cessation.
The aim of the present experiments was to evaluate the
eﬃcacy of a standardized protocol of TEAS in alleviating the
urge to smoke in nicotine-dependent individuals, during a
26-h abstinence period. Two exploratory studies were per-
formed at Singapore’s National University Hospital (NUH).
The ﬁrst (Experiment 1) was a pilot study to investigate the
eﬃcacy of TEAS as a method for relieving acute cravings in
a controlled situation, where smokers were not allowed to
smoke [25]. This experiment was initiated in March 2005
to assess the feasibility, the acceptability by the subjects and
the dropout rate. Based on the ﬁndings obtained in the ﬁrst
study, a second study (Experiment 2) was implemented in
November2005 to evaluate the eﬀect of three diﬀerent TEAS
stimulations on the urge to smoke; this study included a
true placebo (zero stimulation) and, a proxy of placebo (very
weak stimulation). The TEAS device and the conditions of
the outline were specially designed to ascertain the validity
of double-blind; and a guess test was performed with both
research subjects and investigators to validate the blinding,
and to ascertain that the subjects and the investigators were
unable to identify the placebo intervention.
2.Methods
2.1. Study Design. Two studies were performed consecu-
tively.Bothweresingle-center,randomizedanddouble-blind
pilot studies evaluating smoking urges in smokers with a
Fagerstr¨ omscorehigherthan4(Fagerstr¨ omTestforNicotine
Dependence, FTND [26]), while receiving several modalities
of TEAS treatment during a 26-h abstinence period.
Intheﬁrststudy(Experiment1),atotalof40participants
(38 males and 2 females) were recruited through the NUH
clinical trial unit database (n = 23), and through street inter-
views (n = 17) and they were randomized by using the web
randomization software (http://www.randomization.com/)
into two parallel groups: 20 subjects receiving 10mA TEAS
stimulations and 20 subjects receiving 5mA TEAS stimula-
tions. The intensity of the latter corresponds to a threshold
value of tingling sensation to ensure double-blinding as
muchaspossible.Atthislevelofstimulation,thesubjectfeels
that he/she is receiving treatment, but very little analgesic
eﬀect could be observed according to our earlier human
studies on pain modulation. However, the concern that the
continuous 5mA TEAS also represents a form of active
treatment cannot be rejected.
Forthesecondstudy(Experiment2),atotalof58partici-
pants (49 males and 9 females) were recruited through street
interviews and randomized (via http://www.randomization
.com/) into three groups: participants were given either con-
tinuous TEAS treatment at 10mA (n = 21), an intermittent
( 3m i no na n d7m i no ﬀ)T E A Sa t5m A( i 5m A )( n = 20) or
a placebo TEAS with no electrical stimulation (0mA) (n =
17). The i5mA intensity represents an extremely weak, but
still sensible stimulation.
Subjects in both groups received four TEAS sessions:
one session was performed on Day 1 (18:00h in the non-
abstinent state and three sessions on Day 2 (08:30, 12:30 and
16:30 h) while abstaining from smoking.
2.2. Participants. Participants were prescreened, to ensure
that they had an FTND score equal to or >4, having smoked
at least 15 cigarettes a day 12 months prior to enrollment,
and had no intention to quit during the study. Participants
were not included if they had any earlier experience with
transcutaneous electric nerve stimulation (TENS), TEAS,
EA or manual acupuncture or if they used any nicotine
replacement therapies or “stop smoking” therapies during
the 3-month period prior to enrollment in the present
study.Subjectswithpacemakers,ahistory ofchronic medical
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were also not included. Participants were required to sign a
written informed consent to participate and to stop smoking
from the Friday evening 18:00h until Saturday evening 20:00
h, for exactly 26 h. Participants were paid SGD100 for their
participation in each experiment. Both study protocols were
approved by the NUH Ethics Committee and implemented
in the NUH Clinical Trial Unit (CTU).
2.3. Transcutaneous Electrical Acupoints Stimulation. The
TEAS device (HANS LH-202, Huawei Co. Beijing, China)
is a dual-channel acupoint nerve stimulator with two pairs
of constant current electric output. The frequency of the
output stimulation is an alternating dense-and-disperse
mode, where the 2Hz (0.6-ms pulse width) stimulation is
alternated with 100Hz stimulation (0.2-ms pulse width)
automatically, each lasting for 3 s. The device is connected
to the subject via four carbon-pad adhesive electrodes at
fouracupoints. They are Hegu (LI4,located at the mid-point
of the second metacarpus on the radial side), and Laogong
(PC8, mid-way between the second and third metacarpus
on the palmal side, where one’s middle ﬁnger falls when
one makes a ﬁst) in the same hand to form an electric
circuit. The other two points are: Nei Guan (PC6, 2   above
the palm, between the palmaris longus and ﬂexor carpi
radialis tendon), and Wai Guan (TE5, 2   above the skin
crease on the back of the wrist, between the ulnar and
radius)locatedontheoppositeforearmtocompleteacircuit.
Earlier observations revealed no adverse eﬀects of these
stimulations, except for very rare instances of skin irritation,
such as redness beneath or around the electrodes, which
usually disappeared in 1-2 h.
In the ﬁrst study (Experiment 1), a specially designed
control-TEAS device was used for the control group, which
capped the output intensity to 5mA, even if the investigator
selected the protocol-required intensity of 10mA.
In the second study (Experiment 2), the same control-
TEAS device (capped at 5mA) was used but was combined
with a speciﬁc-switching device programmed to switch the
stimulation on for 3min and oﬀ for 7min (the i5mA
group), ortotally blockingthe stimulation from reaching the
subject (the 0mA group). A ﬂashing signal indicated that
the treatment was in progress; this was added to enhance the
blinding further.
In both the studies, the hands of the subject were placed
in an opaque box when receiving stimulation, so that the
participants and the investigators could not observe the
amplitude of the ﬁnger movements and guess the relative
intensity he/she was receiving.
2.4. Guess Test. Moreover, to ascertain the validity of the
double-blind, all the participants were asked to complete a
guess test at the end of each session which comprised of the
following questions:
(1) “Do you believethat yourTEAS unit was functioning
properly”? The answers ranged from “I am certain it was
working properly” to “I am certain it was not working”, and
scored from 0 to 4.
(2) “If your answer is that you had absolutely no idea
whether the unit was functioning or not, what would you
guess”? The answer could be either “Functioning properly”
or “Not functioning properly”.
At the end of each session, the investigators also com-
pleted an observer guess test containing the same aforemen-
tioned two questions.
2.5. Outcome Measures. The primary outcome measure was
the total score of smoking urges as assessed by the 10-
item Questionnaire of Smoking Urges-Brief (QSU-Brief)
[27]. The QSU-Brief is derived from the multidimensional
QuestionnaireofSmokingUrges(QSU)[28].TheQSU-Brief
has been demonstrated to be sensitive to urges occurring
during acute cigarettes abstinence [27]. This questionnaire
has been validated [27] in both a laboratory setting, and
an outpatient smoking cessation clinic. The QSU-Brief can
be completed in 2min. Participants respond by ticking
the desired score between “strongly agree” and “strongly
disagree” onaseven-pointLikertscale.The totalscoreranges
from 10 to 70, and the subscores for each factor range from
5 to 35. The QSU questionnaire was administered at time 0
before participants stopped smoking and then at 2, 14, 18,
22, 24 and 26h after the last cigarette was smoked.
Systolic blood pressure (SBP), diastolic blood pressure
(DBP) and pulse rate (PR) were recorded by using GE Mar-
quette Dash 3000 Bedside Patient Monitoring System. Body
temperature (◦C),(measuredorallyusingtheTerumoDigital
Clinical Thermometer, Model C0402), and respiration rate
(breaths per minute, BPM) were recorded each time just
before the participants completed the QSU questionnaire.
Carbon monoxide (CO) levels in the expired air using a
CO monitor (Minismokerlyzer, Bedfont Scientiﬁc Limited,
UK) were measured before the participants stopped smok-
ing, and during abstinence at 14, 18, 22, 24 and 26h after
the last cigarette was smoked. Blood samples for plasma
cotinine determinations were drawn at baseline and at 14
and 22h after smoking was stopped. Plasma cotinine con-
centrations were determined by chemiluminescence using
Immulite 2000 (Diagnostic Products Corporation, USA).
The reference limit is <25ngml−1 for non-smokers. The
assay sensitivity is 5ngml−1 with a within-run precision of
4.0–9.9%.
2.6. Study Procedures. The screening/enrollment was per-
formed for not >10 days before the participants started the
study. The study was initiated on a Friday evening at 18:00 h,
and lasted until Saturday evening 20:00 h.
For both the studies, 18–20 participants were assessed
during each session. All participants were instructed to
smoke their last cigarettes upon their arrival at the study
center,andthennottosmokeagainuntiltheendofthestudy.
Participants were allowed to go back home for the night.
2.7. Statistical Analyses. The categorical variables of demo-
graphics and clinical characteristics were summarized by
frequency, whereas the continuous variables were summa-
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The frequency of categorical parameters between the groups
w a sc o m p a r e dw i t hP e a r s o n ’ sc h i - s q u a r e dt e s t ,a n dF i s h e r ’ s
exact test was used if the expected count by cell was less
than ﬁve. Continuous variables between the two indepen-
dent groups were compared with the Mann-Whitney non-
parametric test.
All the responses from the 10-question QSU-Brief were
summed upas a single score (minimum score, 10; maximum
score,70)foreachparticipantateachpredeﬁnedtimepoints,
and was compared between treatment arms as a function of
time. On separate factor analysis of QSU scores, according to
Cox et al. [27], QSU scores from questions 1, 3, 6, 7 and 10
were summed up as Factor 1 (positive reinforcement), and
the other questions (2, 4, 5, 8 and 9) of the QSU-Brief were
summed up as Factor 2 (negative reinforcement).
ThevariationsinthemeanQSUscoresacrosstimepoints
by each treatment arm were plotted. Exploratory graphical
presentation suggested that a growth curve quadratic model
m i g h tb eu s e dt oﬁ tt h eo b s e r v e dQ S Us c o r e sa saf u n c t i o n
of time. Each interaction term was tested and the covariate,
Time and quadratic term, Time2, were signiﬁcant univariate
terms, which were included in the ﬁtted model. All the
models were adjusted by the covariate: age. Gender was not
a signiﬁcant covariate term in the quadratic model, and was
not included in the ﬁtted models. Growth-curve quadratic
model was used to analyze the trend of both Factors 1 and 2
between arms as a function time. Likewise, all models were
adjusted by covariate age. The predeﬁned time points were
entered as t = 0, 1, 2, ...6 for time 0, 2, 14, 18, 22, 24 and
26h after the last cigarette was smoked. Missing values were
not imputed.
All analyses were performed on SAS (Version 9.1, SAS
Institute Inc., Cary, NC, USA). A two-sided P < .05 was
considered signiﬁcant.
3.Results
3.1. Demographic and Smoking Characteristics of the Partici-
pants. The relevant data inExperiments1 and 2 are depicted
in Table 1. Around half of the participants were of Chinese
origin while the others were of Indian, Malay or Indonesian
origin. There were no statistically signiﬁcant diﬀerences
between the groups in either study regarding gender, race,
age, number of cigarettes smoked per day, duration of
smokingandFTNDscore(Table 1).Inaddition,therewasno
signiﬁcant diﬀerence in the expired CO and plasma cotinine
levels between the study groups, either at baseline or during
smoking abstinence.
3.2.Inclusions andExclusions. Threeparticipantsinthe5mA
arm, one participant in the 10mA arm of Experiment 1
decided to stop the study. Two participants from each arm
of Experiment 2 did not return to the center overnight after
the second QSU, and one participant of the 0mA group did
not continue the treatment after the fourth QSU assessment.
A total of nine minor adverse events were reported by the
participants. In the 10mA arm, one patient reported a runny
nose and coughing 14h after the last cigarette, and one
patient experienced giddiness after blood drawn at time
0, and numbness in a ﬁnger after 2 h, and this subject
decided not to complete the study. In the i5mA group,
three participants reported a runny nose and one reported
insomnia. In the 0mA group, one participant reported a
runny nose after 14h and did not complete the study, one
reported giddiness, and one reported numbness in the left
hand.
3.3. Analysis of the Guess Tests. Analysis performed in Exper-
iments 1 and 2 showed that the participants were unable to
distinguish which stimulations they received (Fisher’s exact
test: P = .44 and P = .66, resp.). Observer guess scores were
similar across groups in both Experiments 1 and 2 (Fisher’s
exact test: P = 1.0 and P = .8, resp.). Thus, the eﬃcacy
analyses could be performed.
3.4. Experiment 1. The average baseline QSU scores were
42.6 ± 15.20 and 36.8 ± 14.96 (mean ± SD) in the 10 and
5mA group, respectively, showing no signiﬁcant diﬀerence.
The ﬁtted quadratic model showed that there was no
signiﬁcant condition by time interaction (P = .89and .96,for
ﬁrst- and second-order interaction terms, resp.). Further, no
diﬀerence occurred either for Factor 1 (P = .53) or for Factor
2( P = .29) (data not shown) of the QSU-Brief. As seen in
Figure 1, (a) shows mean QSU change scores from baseline.
3.5. Experiment 2. The average QSU scores for the baseline
of 10, i5 and 0mA groups were 43.62 ± 17.37, 42.5 ±
14.64and39.29 ±16.44,respectively,showing nostatistically
signiﬁcant diﬀerence. There was no main eﬀect of condition,
and the ﬁtted quadratic model showed that there was no
signiﬁcant condition by time interaction (P = .19and .24,for
ﬁrst- and second-order interaction terms, resp.). As seen in
Figure 1, (b) shows mean QSU change scores from baseline.
Moreover, analysis of Factors 1 and 2 showed no main eﬀect.
3.6. Exploratory Analyses in Subjects with FTND Score ≥4. In
the exploratory analyses of Experiment 2, interventions were
dichotomizedintocontrolarmconsistingof0andi5mA(n=
37) and active arm consisting of 10mA (n = 21). Statistical
analysis of the ﬁrst- and second-order interactions showed
that there was a tendency toward signiﬁcant condition by
time interaction (P = .09 and .11, resp.), the increase in
QSU during abstinence being somewhat less in the 10mA
condition than in the control condition.
There was no signiﬁcant condition by time interaction
for Factor 1 (P = .12 and .2 for ﬁrst- and second-order
interaction terms, resp.) but a signiﬁcant condition-by-time
interaction occurred for Factor 2 (P = .005 and .017 for ﬁrst-
and second-order interaction terms, resp.).
3.7. Exploratory Analyses in Subjects with FTND ≥5. When
only subjects with FTND scores ≥5 were selected (n =
35 for control arm and n = 20 for the 10mA arm), a
signiﬁcant ﬁrst-order condition by time interaction was
observed (P = .02) (Figure 2). The second-order interaction
showed a tendency toward signiﬁcant activity (P = .056).Evidence-Based Complementary and Alternative Medicine 5
Table 1: Demographic and smoking characteristics of subjects participating in Experiment 1 and 2.
Experiment 1 Experiment 2
Treatment condition
5mA 10mA 0mA i5mA 10mA
(N = 20) (N = 20) (N = 17) Placebo (N = 20) A proxy of placebo (N = 21)
Gender (N,% )
Female 0 (0) 2 (10) 2 (12) 7 (35) 6 (29)
Male 20 (100) 18 (90) 15 (88) 13 (65) 15 (71)
Age (years), Mean ± SD 30.8 ± 6.47 30.5 ± 8.78 25.9 ± 4.75 23.5 ± 3.58 24.7 ± 4.85
Number of cigarettes per
day Median (range)
20 (15–35) 18.5 (15–28) 19 (15–28) 18.3 (15–25) 17.0 (15–23)
Years of smoking
Median (range)
14 (5–31) 13.5 (6–38) 9.0 (1–23) 7.5 (4–13) 8.0 (5–28)
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Figure 1: Mean QSU changes from baseline in Experiments 1 (a)
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18h30 8h30 12h30 16h30
10mA
Control group (0mA+i5mA)
Figure 2: Mean QSU changes from baseline in Experience 2.
The two placebo conditions (0mA and i5mA) were merged into
control condition and compared to the 10mA condition. Subjects
with FTND∗ ≥5 were included. Arrows indicate TEAS. Error bars
indicate SEM.
A signiﬁcant condition-by-time interaction for Factor 2 was
also found (P = .017 and .054, for ﬁrst- and second-order
interaction terms, resp.), but not for Factor 1. In both the
experiments, no diﬀerence was observed between any of the




4.1.1. The Design of the Control Group. The diﬃculty of de-
signing a control group for acupuncture lies in the fact that
acupuncture by itself produces sensations and subjective
feelings, the so-called “Deqi” sensation [29]. To provide the
subject with a credible acupuncture sensation, yet limiting
the therapeutic eﬀect, a minimal stimulation modality is6 Evidence-Based Complementary and Alternative Medicine
often used [30]. The key point resides in the choice of the
optimal intensity for the control stimulation. The TEAS
device used in the present study delivers constant current
electrical stimulation. The threshold intensity for producing
a tingling sensation was found to be 5mA in most cases.
Therefore, in the ﬁrst study, we used the threshold intensity
of 5mA for control, and doubled the threshold value to
10mA as the active intensity. However, the results showed
that the changes in the degree of the urge to smoke were
similar. Thiscouldbeinterpretedtomeanthat(i)noneofthe
two treatments was eﬀective, or (ii) a minimal stimulation
was already eﬀective.
4.1.2. The Design of a Device Used as Placebo/Control Treat-
ments. Eliminating and reducing any bias is a major goal
of controlled studies [31–33]. After an exhaustive review
of available publications on blinding physical therapies, we
determined that while there is no room for further reducing
the intensity of the threshold stimulation, and at the same
time keeping the tingling sensation, we tried to reduce the
length of stimulation. By inserting a brake device between
the output sockets of the TEAS and the skin electrodes, we
were able to control the timing of the stimulation in a 3min
on and 7min oﬀ schedule (designated as Intermittent 5 or
i5mA group). The subjects in this group could clearly feel
the tingling sensation from time to time, which may have
helped convince the subject that real electrical stimulation
is delivered to the stimulation sites. The inconvenience of
a placebo electrical stimulation (0mA) is that the subject
can guess with a relatively high likelihood that there is no
stimulation (no skin sensations); the inconvenience for a
proxy of a placebo electrical stimulation (i5mA) is that even
an intermittent and a very weak stimulation may have some
biological eﬀect. Being unsure of the validity of these two
alternatives, we decided to design two placebo groups: 0
and i5mA. The guess tests showed that the subjects could
not distinguish between the interventions. Given the strong
placebo eﬀect, it is evident from Figure 1(a) that the eﬀect
induced by i5mA was almost identical with that produced
by the blank control (0mA), suggesting that this mode of
stimulation was too weak to producea measurable biological
eﬀect.Moreover, the main statistical analysis showed that the
estimatedcoeﬃcientsofthe0andi5mAarmswereveryclose
together and far from the estimated coeﬃcientsof the 10mA
arm. The results obtained from the 0 and i5mA group were
thus merged to form a single control group.
4.1.3. Features to Promote Blinding of Subjects and Investi-
gators. These features include the use of “placebo” TEAS
devices that are visually identical to active devices, exclusion
ofpatientswithearlierTEAS/acupuncture/TENSexperience,
use of identical protocol/visit schedule, avoidance of treat-
ment discussion between participants and clinicians, and the
use of visual signals. In addition, the subjects’ hands were
hidden in a box so that neither the investigators nor the
subjects could assess the amplitude of the subjects’ ﬁnger
movements due to electrical stimulations, and ﬁnally each
participant was explained that “each of the three treatment
modalitieswassetwithdiﬀerentlevelsofintensity,frequency,
duration or administration mode, and that some of these
parameters such as intensity are more stimulatory than
others”.Hence,theywouldprobablyfeelsomesensationwith
high-intensity stimulations and no sensation with high-
frequency stimulations which could nevertheless be as eﬀec-
tive. This design proved successful, as the guess test showed
that the double-blinding was not compromised.
4.2. Mode of Acupuncture. Considering the future potential
application of the technique by the smokers at home, we
chose the TEAS instead of manual needling.
Concerning the criteria of choosing the four acupoints,
the Hegu point is known to be the most powerful point
to produce an analgesic eﬀect via the increase of release of
opioid peptides, which are released in the CNS [19], whereas
Neiguan, a strategic point of the pericardial meridian is
known to produce a calming or anxiolytic eﬀect according
to traditional Chinese medicine. When EA or TEAS is used
instead of manual needling, it is advisable to use the close-by
point to complete an electric circuit rather than to use the
point in the opposite extremity, thereby letting the current
passthroughthecardiacregion.Repeateduseofacupuncture
is needed for most of the therapeutic interventions. In the
treatment of heroin addiction with TEAS, it was used three
times a day in the ﬁrst 5 days of drug abstinence, followed
by twice a day for the following 5 days, and ending with
once a day for the rest of the detoxiﬁcation period of 15
days [22]. From a clinical point of view, repeated use seems
to be necessary for eﬀective symptom control. However, too
frequenta use,forexample,4–6timesaday,will unavoidably
lead tothedevelopmentoftolerance[34].Therefore, athree-
times-a-day schedule was used in the present study.
4.3. Exploratory Analysis. Participants for these two studies
were included only if they had FTND scores >4, because the
urge to smoke (or craving) increases with higher tobacco
dependence[35]. Ourresultsshowed that inthis population,
TEAS did not antagonize the increase in urge to smoke.
However, when analyses were limited to participants with
FTND ≥5, 10mA, TEAS did antagonize abstinence-induced
increase in the urge to smoke. A similar pattern has been
observed for the antinociceptive eﬀect of TEAS in rats.
Standardized acupuncture procedure applied to a normal
rat produces an increase of the nociceptive threshold by
80–100%, an eﬀect lasting only for a period of <1h [36].
However, in a rat subjected to neurogenic hyperalgesia
(by the ligation of the lumbar ﬁve and six dorsal spinal
nerve roots), one session of electro-acupuncture for 30min
produced a suppression of hyperalgesia for as long as 24h
[37]. Thus, the eﬃcacy of TEAS seems to depend on
the degree of disturbance of homeostasis: the higher the
deviation from the normal level, the more eﬀective is the ac-
upuncture intervention.
4.4. The Eﬀect of TEAS on Factors 1 and 2. The eﬀect of
TEAStoantagonize theurgeto smokeconcernedonly Factor
2 of the QSU, suggesting that TEAS is more eﬀective inEvidence-Based Complementary and Alternative Medicine 7
reducing an anticipation of relief from negative eﬀect with
an urgent desire to smoke during smoking abstinence. Based
on our systemic study of the neurochemical mechanisms
of acupuncture therapy in animal models [19], it was
evident that TEAS produces a frequency-dependent release
ofopioidpeptidesin the CNS[19, 38]. Lowfrequency(2Hz)
TEAS increases the release of enkephalins, endorphins and
e n d o m o r p h i ni nt h eb r a i nt oi n t e r a c tw i t ht h eμ-a n dδ-
opioid receptors, 100Hz increases the release of dynorphin
inthe spinal cordtointeractwith thekappaopioidreceptors,
whereas 2/100Hz mode has been shown to accelerate the
release of all four kinds of endogenous opioid peptides
[19]. Since chronic nicotine has been shown to inhibit
proopiomelanocortin (POMC) gene expression, and thus
probably, biosynthesis of β-endorphin [39], the activation
of endorphin release by TEAS [38] may play a role in
amelioratingthedeﬁciencyofendorphin.Ontheotherhand,
activationofcentral kappareceptorsisapowerful suppressor
of the withdrawal syndrome in rats made dependent on
morphine [22, 40], and in opiate addicts [41], although it
remains unclear whether it also works in relieving nicotine
withdrawal. Inarecentstudy[42],itwasreportedthatinrats
dependent on nicotine, withdrawal of nicotine resulted in
an anxiety-like behavior. This psycho-neural disorder can be
eﬀectively reduced by acupuncture. The authors attributed
this eﬀect to the negative modulatory eﬀect of acupuncture
to the expression of corticotrophin-releasing factor (CRF) in
the amygdala. Indeed, the CRF mRNA levelsin the amygdala
were signiﬁcantly higher in the nicotine withdrawal group
comparedtothecontrolgroup,andacupuncturebroughtthe
CRF mRNA level down to the control level.
As to the lack of signiﬁcant eﬀect of TEAS on Factor 1
(strong desire and intention to smoke, with smoking per-
ceived as rewarding) of the QSU, one has to consider that
the subjectswere not allowed tosmoke during the26h of the
study, and lack of smoking cannot induce positive reinforce-
ment, so it is not surprising that the TEAS intervention did
not aﬀect the positive reinforcement.
4.5. Limitations. The subjects enrolled in this study were
mainly of Asian origin. Thus, the present results may not be
generalized to smokers of other ethnic origins.
The exploratory analysis showed that only the subgroup
of more dependent smokers showed signiﬁcant antagonism
in the urge to smoke by TEAS, but this analysis was not
planned, which weakens its strength.
Any earlier alcohol or any illicit drug consumption was
not assessed (and controlled for) by structured interview,
which would potentially lead to lower homogeneity of the
population studied.
Finally, we assessed onlya surrogate of smoking cessation
(urge to smoke). The eﬃcacy of TEAS on smoking cessation
should be assessed in therapeutic trials.
5.Conclusions
The results obtained in the present study indicate that appli-
cation of TEAS on the skin is capable of antagonizing the
urge to smoke in dependent smokers. Based on these pre-
liminary ﬁndings, it seems warranted to assess the eﬃcacy
of TEAS in larger populations of dependent smokers, and to
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